vs
Side-by-side financial comparison of Prestige Consumer Healthcare Inc. (PBH) and UNITED FIRE GROUP INC (UFCS). Click either name above to swap in a different company.
UNITED FIRE GROUP INC is the larger business by last-quarter revenue ($365.8M vs $283.4M, roughly 1.3× Prestige Consumer Healthcare Inc.). On growth, UNITED FIRE GROUP INC posted the faster year-over-year revenue change (9.8% vs -2.4%). Over the past eight quarters, UNITED FIRE GROUP INC's revenue compounded faster (11.2% CAGR vs 1.2%).
Prestige Consumer Healthcare Inc. is an American company that markets and distributes over-the-counter healthcare and household cleaning products. It was formed by the merger of Medtech Products, Inc., Prestige Brands International, and the Spic and Span Company in 1996. The company is headquartered in Tarrytown, New York and operates a manufacturing facility in Lynchburg, Virginia.
The United Fruit Company was an American multinational corporation that traded in tropical fruit grown on Latin American plantations and sold in the United States and Europe. The company was formed in 1899 from the merger of the Boston Fruit Company with Minor C. Keith's banana-trading enterprises. It flourished in the early and mid-20th century, and it came to control vast territories and transportation networks in Central America, the Caribbean coast of Colombia, and the West Indies. Althou...
PBH vs UFCS — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $283.4M | $365.8M |
| Net Profit | $46.7M | — |
| Gross Margin | 55.5% | — |
| Operating Margin | 29.1% | 13.2% |
| Net Margin | 16.5% | — |
| Revenue YoY | -2.4% | 9.8% |
| Net Profit YoY | -23.5% | — |
| EPS (diluted) | $0.97 | $1.45 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $283.4M | $365.8M | ||
| Q3 25 | $274.1M | $354.0M | ||
| Q2 25 | $249.5M | $335.5M | ||
| Q1 25 | $296.5M | $331.1M | ||
| Q4 24 | $290.3M | $333.2M | ||
| Q3 24 | $283.8M | $323.0M | ||
| Q2 24 | $267.1M | $301.2M | ||
| Q1 24 | $277.0M | $296.0M |
| Q4 25 | $46.7M | — | ||
| Q3 25 | $42.2M | $39.2M | ||
| Q2 25 | $47.5M | $22.9M | ||
| Q1 25 | $50.1M | $17.7M | ||
| Q4 24 | $61.0M | — | ||
| Q3 24 | $54.4M | $19.7M | ||
| Q2 24 | $49.1M | $-2.7M | ||
| Q1 24 | $49.5M | $13.5M |
| Q4 25 | 55.5% | — | ||
| Q3 25 | 55.3% | — | ||
| Q2 25 | 56.2% | — | ||
| Q1 25 | 57.3% | — | ||
| Q4 24 | 55.5% | — | ||
| Q3 24 | 55.5% | — | ||
| Q2 24 | 54.7% | — | ||
| Q1 24 | 54.8% | — |
| Q4 25 | 29.1% | 13.2% | ||
| Q3 25 | 29.1% | 13.7% | ||
| Q2 25 | 28.8% | 8.7% | ||
| Q1 25 | 29.8% | 6.6% | ||
| Q4 24 | 31.7% | 11.9% | ||
| Q3 24 | 29.7% | 7.7% | ||
| Q2 24 | 27.0% | -1.3% | ||
| Q1 24 | 29.7% | 5.5% |
| Q4 25 | 16.5% | — | ||
| Q3 25 | 15.4% | 11.1% | ||
| Q2 25 | 19.0% | 6.8% | ||
| Q1 25 | 16.9% | 5.3% | ||
| Q4 24 | 21.0% | — | ||
| Q3 24 | 19.2% | 6.1% | ||
| Q2 24 | 18.4% | -0.9% | ||
| Q1 24 | 17.9% | 4.6% |
| Q4 25 | $0.97 | $1.45 | ||
| Q3 25 | $0.86 | $1.49 | ||
| Q2 25 | $0.95 | $0.87 | ||
| Q1 25 | $1.00 | $0.67 | ||
| Q4 24 | $1.22 | $1.22 | ||
| Q3 24 | $1.09 | $0.76 | ||
| Q2 24 | $0.98 | $-0.11 | ||
| Q1 24 | $0.98 | $0.52 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $62.4M | $156.3M |
| Total DebtLower is stronger | $1.0B | — |
| Stockholders' EquityBook value | $1.8B | $941.2M |
| Total Assets | $3.5B | $3.8B |
| Debt / EquityLower = less leverage | 0.56× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $62.4M | $156.3M | ||
| Q3 25 | $119.1M | $233.7M | ||
| Q2 25 | $139.5M | $202.1M | ||
| Q1 25 | $97.9M | $183.7M | ||
| Q4 24 | $50.9M | $200.9M | ||
| Q3 24 | $51.5M | $197.4M | ||
| Q2 24 | $34.3M | $153.4M | ||
| Q1 24 | $46.5M | $217.8M |
| Q4 25 | $1.0B | — | ||
| Q3 25 | $993.1M | — | ||
| Q2 25 | $992.7M | — | ||
| Q1 25 | $992.4M | — | ||
| Q4 24 | $992.0M | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | — | ||
| Q1 24 | $1.1B | — |
| Q4 25 | $1.8B | $941.2M | ||
| Q3 25 | $1.8B | $898.7M | ||
| Q2 25 | $1.9B | $845.7M | ||
| Q1 25 | $1.8B | $817.7M | ||
| Q4 24 | $1.8B | $781.5M | ||
| Q3 24 | $1.7B | $785.8M | ||
| Q2 24 | $1.7B | $726.6M | ||
| Q1 24 | $1.7B | $736.8M |
| Q4 25 | $3.5B | $3.8B | ||
| Q3 25 | $3.4B | $3.8B | ||
| Q2 25 | $3.4B | $3.7B | ||
| Q1 25 | $3.4B | $3.5B | ||
| Q4 24 | $3.3B | $3.5B | ||
| Q3 24 | $3.3B | $3.5B | ||
| Q2 24 | $3.3B | $3.4B | ||
| Q1 24 | $3.3B | $3.2B |
| Q4 25 | 0.56× | — | ||
| Q3 25 | 0.54× | — | ||
| Q2 25 | 0.54× | — | ||
| Q1 25 | 0.54× | — | ||
| Q4 24 | 0.55× | — | ||
| Q3 24 | 0.61× | — | ||
| Q2 24 | 0.65× | — | ||
| Q1 24 | 0.68× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $78.3M | $269.7M |
| Free Cash FlowOCF − Capex | $75.3M | — |
| FCF MarginFCF / Revenue | 26.6% | — |
| Capex IntensityCapex / Revenue | 1.1% | — |
| Cash ConversionOCF / Net Profit | 1.68× | — |
| TTM Free Cash FlowTrailing 4 quarters | $267.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $78.3M | $269.7M | ||
| Q3 25 | $57.5M | $60.8M | ||
| Q2 25 | $79.0M | $53.4M | ||
| Q1 25 | $61.8M | $35.7M | ||
| Q4 24 | $65.1M | $340.3M | ||
| Q3 24 | $69.8M | $56.5M | ||
| Q2 24 | $54.8M | $91.3M | ||
| Q1 24 | $66.9M | $36.2M |
| Q4 25 | $75.3M | — | ||
| Q3 25 | $55.4M | — | ||
| Q2 25 | $78.2M | — | ||
| Q1 25 | $58.4M | — | ||
| Q4 24 | $63.5M | — | ||
| Q3 24 | $67.8M | — | ||
| Q2 24 | $53.6M | — | ||
| Q1 24 | $63.8M | — |
| Q4 25 | 26.6% | — | ||
| Q3 25 | 20.2% | — | ||
| Q2 25 | 31.3% | — | ||
| Q1 25 | 19.7% | — | ||
| Q4 24 | 21.9% | — | ||
| Q3 24 | 23.9% | — | ||
| Q2 24 | 20.1% | — | ||
| Q1 24 | 23.0% | — |
| Q4 25 | 1.1% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 1.2% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 0.4% | — | ||
| Q1 24 | 1.1% | — |
| Q4 25 | 1.68× | — | ||
| Q3 25 | 1.36× | 1.55× | ||
| Q2 25 | 1.66× | 2.33× | ||
| Q1 25 | 1.23× | 2.02× | ||
| Q4 24 | 1.07× | — | ||
| Q3 24 | 1.28× | 2.86× | ||
| Q2 24 | 1.12× | — | ||
| Q1 24 | 1.35× | 2.68× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PBH
| Womens Health | $51.8M | 18% |
| International OTC Healthcare | $47.7M | 17% |
| Gastrointestinal | $44.2M | 16% |
| Eye And Ear Care | $35.2M | 12% |
| Dermatologicals | $27.6M | 10% |
| Analgesics | $26.7M | 9% |
| Oral Care | $23.5M | 8% |
| Cough And Cold | $23.0M | 8% |
| Other Otc | $3.6M | 1% |
UFCS
Segment breakdown not available.
